insights_auto
Outlook: 65.7% bullish·0.0% bearish
Go to analysischevron_right
UTHR:NASDAQ
United Therapeutics Corp
$587.50
arrow_upward
+0.46%(+2.71) 1D
$587.50
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$584.92
High
$590.98
Low
$576.24
Mkt. cap
25.20B
Avg. vol.
917.96K
Volume
637.88K
P/E ratio
21.01
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
Open
$584.92
High
$590.98
Low
$576.24
Mkt. cap
25.20B
Avg. vol.
917.96K
Volume
637.88K
P/E ratio
21.01
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Billionaires.Africa
·
22 hours ago
U.S. transgender billionaire Martine Rothblatt sells $5.5 million in United Therapeutics stock
Investing.com
·
1 day ago
Martine Rothblatt, United Therapeutics CEO, sells $5.5M in stock
Investing.com Canada
·
2 days ago
United Therapeutics CEO Rothblatt sells $5.3m in UTHR stock By Investing.com
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com